Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Robin Hoogenboom

1PUBLICATIONS

9CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jun 22, 2022

Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy Efficacy.

Floris Dammeijer, Mandy van Gulijk, Larissa Klaase

Pageof 1

Frequent Collaborators

1 joint publications

Floris Dammeijer

1 joint publications

Mandy van Gulijk

1 joint publications

Larissa Klaase

1 joint publications

Menno van Nimwegen

1 joint publications

Rachid Bouzid

1 joint publications

Maria E Joosse

1 joint publications

Rudi W Hendriks

1 joint publications

Thorbald van Hall

1 joint publications

Joachim G Aerts

Frequent Collaborators

1 joint publications

Floris Dammeijer

1 joint publications

Mandy van Gulijk

1 joint publications

Larissa Klaase

1 joint publications

Menno van Nimwegen

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

See more related videos

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

See more related videos